cardiovascular prevention

Dublin, Ireland & Bridgewater, N.J. – August 28, 2026 Amarin Corporation announced new post hoc findings from the landmark...

HAMBURG & MUNICH, March 5, 2026 Daiichi Sankyo Europe and GAIA, a global pioneer in evidence-based digital therapeutics, have...

THOUSAND OAKS, Calif., Oct. 1, 2025 — Amgen announced that its landmark VESALIUS-CV Phase 3 trial met primary endpoints...